Mechanisms underlying T helper suppression by regulatory T cells
Mechanisms underlying T helper suppression by regulatory T cells
批准号:
7796696
负责人:
Ayana Jordan
金额:
$0.9万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-11 至 2009-08-10
关键词:
Antigen-Presenting CellsAutoimmune DiseasesAutoimmunityBehaviorBiological AssayCD4 Positive T LymphocytesCalciumCell CommunicationCell NucleusCell physiologyCellsCoculture TechniquesComplexCytoplasmCytotoxic T-LymphocytesDNADNA BindingEffector CellElectrophoretic Mobility Shift AssayEpigenetic ProcessFamily memberGene ExpressionGenesGoalsHelper-Inducer T-LymphocyteHistone Deacetylase InhibitorHistone DeacetylationHistonesHomeostasisIL2 geneImmune ToleranceImmune systemImmunofluorescence ImmunologicInbred BALB C MiceInterleukin-2InterleukinsJordanMaintenanceMalignant NeoplasmsMature T-LymphocyteMediatingMembraneModificationMolecularMusPatternPeripheralPlayPopulationProcessPromoter RegionsProteinsReceptor SignalingRecruitment ActivityResearchResistanceRestRoleSignal PathwaySignal TransductionSystemT-Cell ActivationT-Cell ReceptorT-LymphocyteTh1 CellsTherapeutic UsesThymus GlandTranscription Factor AP-1Transcriptional ActivationTranscriptional RegulationTransgenic OrganismsTrichostatin Aanergyautoreactive T cellcell typechromatin immunoprecipitationchromatin remodelingcytokinehuman diseasemembernovelnuclear factors of activated T-cellspromoterprotein expressiontherapy developmenttranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to elucidate the changes that occur within T helper (Th) cells when suppressed by regulatory T cells (Tregs) and identify the molecular mechanisms underlying Treg mediated inactivation of effector T cell functions. The specific aims of this project include (1) characterizing the role of Nuclear Factor of Activated T cells (NFAT) within suppressed T cells, identifying the molecular mechanisms of activation, transcriptional partners and the interaction with downstream targets; and (2) determining if Treg function is controlled by silencing of the interleukin (IL-)2 gene. To approach the first aim, immunofluorescence will reveal if NFAT is retained in the cytoplasm or translocated across the membrane, where it is active and can induce the expression of proteins known to suppress T cell activation. Electrophoretic mobility shift assays will be used to determine if active NFAT proteins can bind DNA in the nucleus of suppressed Th cells, in the absence of AP-1. Subsequently, chromatin immunoprecipitation (ChIP) will be performed on suppressed Th1 cells to determine if activation by NFAT involves direct recruitment of this protein to the promoter regions of T cell inactivating genes. By completing our goals in aim one we intend to uncover the transcriptional regulation of NFAT activation within suppressed T cells and elucidate gene expression patterns that are necessary for the induction and maintenance of the unresponsive state. For the second aim, chromatin immunoprecipitation assays will determine if epigenetic modifications regulate IL-2expression in stimulated Tregs and suppressed Th cells. To study the role of histone deacetylation in the suppressor activity and function of Tregs, isolated Tregs from BALB/c mice will be cocultured with TCR transgenic D011.10 mice and stimulated in the presence or absence of the histone deacetylase inhibitor, Trichostatin-A. Our overall goal in aim two is to determine the role that chromatin remodeling plays in the induction of T cell tolerance and investigate the mechanisms that regulate cytokine expression in Tregs and in Treg-mediated suppression of Th cells. A clear understanding of how theIL-2 locus is regulated in both Tregs and suppressed cells will prove invaluable in elucidating Treg behavior and function. By uncovering the mechanisms of Treg-mediated suppression of effector T cell function, novel therapies inducing immune tolerance can be developed against a host of autoimmune diseases and cancers. This project is relevant to the public at large because of the importance this cell (Treg) plays in maintaining a healthy immune system. By studying the behavior of this cell type (Treg), the causes of different human diseases can be better understood and new therapies developed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing health disparities by providing evidence-based treatment in the Black Church
-
批准号:10721580
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2023
-
负责人:Ayana Jordan
-
依托单位:
Liberating methadone: Building a roadmap and community for change
-
批准号:10683560
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2023
-
负责人:Ayana Jordan
-
依托单位:
Culturally Response Integrated Harm Reduction Services for Black and Latinx People Who use Drugs
-
批准号:10590442
-
项目类别:
-
资助金额:$212.56万
-
财政年份:2022
-
负责人:Ayana Jordan
-
依托单位:
Addressing health disparities by providing evidence-based treatment in the Black Church
-
批准号:10100442
-
项目类别:
-
资助金额:$70.81万
-
财政年份:2020
-
负责人:Ayana Jordan
-
依托单位:
Addressing health disparities by providing evidence-based treatment in the Black Church
-
批准号:10689694
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2020
-
负责人:Ayana Jordan
-
依托单位:
Addressing health disparities by providing evidence-based treatment in the Black Church
-
批准号:10544963
-
项目类别:
-
资助金额:$59.61万
-
财政年份:2020
-
负责人:Ayana Jordan
-
依托单位:
Addressing health disparities by providing evidence-based treatment in the Black Church
-
批准号:10473530
-
项目类别:
-
资助金额:$56.17万
-
财政年份:2020
-
负责人:Ayana Jordan
-
依托单位:
Addressing health disparities by providing evidence-based treatment in the Black Church
-
批准号:10265527
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2020
-
负责人:Ayana Jordan
-
依托单位:
Mechanisms underlying T helper suppression by regulatory T cells
-
批准号:7487619
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2008
-
负责人:Ayana Jordan
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: